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Abstract
This commentary highlights the contribution of the article by
Chapman and colleagues assessing the relationships between
glucose absorption, glycaemia and gastric emptying during critical
illness. In addition to several more expected findings, their data
suggest that factors other than slow gastric emptying may limit
glucose absorption during critical illness. This hypothesis has
received little attention so far, although numerous small intestinal
abnormalities possibly interfering with absorption are known to
occur in intensive care patients. Future work should focus on
further validation of tools to assess nutrient absorption in the
critically ill, before defining the precise causes and mechanisms
that are involved.
In a recent issue of Critical Care, Chapman and colleagues
[1] report a study aiming to quantify glucose absorption and
the relationships between gastric emptying, glucose absorp-
tion and glycaemia in critically ill patients. This study follows
many publications from the same Australian group that have
contributed greatly to better our understanding of gastro-
intestinal failure during critical illness [2]. They analysed the
kinetics of glucose absorption, glycaemia modifications, and
gastric emptying after a test meal in 19 critically ill patients,
with comparison to healthy volunteers. The test meal was
administered by nasogastric bolus, however, a modality of
administration somewhat different from the classic con-
tinuous intragastric infusion. Some of their findings were
expected from previous work, while others clearly challenge
our present beliefs.
In agreement with many previous studies [2,3], the rate of
gastric emptying was reduced in critically ill patients and,
consequently, the rate of glucose absorption was found to be
reduced. Glucose absorption in this study was measured
using 3-O methylglucose (3-O MG). Like glucose, 3-O MG is
actively absorbed by enterocytes (through sodium glucose
co-transporter-1), but it is not metabolized; therefore, kinetic
parameters obtained from sequential plasma concentrations
as well as urinary excretion following digestive administration
have been used as markers of glucose absorption [4,5].
Since absorption of this sugar occurs almost exclusively in
the intestine, gastric emptying should logically influence the
rate of 3-O MG absorption after intragastric administration,
an observation that Chapman and colleagues confirmed.
The finding that 3-O MG absorption is still decreased in the
subset of patients with normal gastric emptying is more
surprising, however, and calls out for additional explanation.
Besides gastric emptying, numerous factors may theoretically
influence the kinetics of 3-O MG absorption, including
mucosal integrity, the number of sodium glucose co-trans-
porters, small intestine peristalsis, blood flow, the volume of
distribution of the substance, and alterations in renal
clearance [4,6].
The hypothesis of impaired intestinal absorption of glucose in
critically ill patients has received little attention so far; indeed,
many ICU physicians still consider that nutrients are
absorbed completely provided that they have passed beyond
the pylorus. Increasing evidence may indicate, however, that
this concept is obsolete, and energy loss through mal-
absorption may be an overlooked problem in ICU patients.
Using bomb calorimetry, a method to quantify the energetic
losses in faecal material, investigators demonstrated sub-
stantial loss of calories in the faeces of ICU patients, most of
them fed postpylorically [7]; in 13 patients with a faeces
collector because of loose stools, the caloric value of energy
loss was a mean of 301 kcal/day, and 3 patients had a loss of
more than 500 kcal/day in the stools [7].
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Decreased intestinal absorption in ICU patients may con-
ceivably be multifactorial; gut mucosal atrophy and decreased
splanchnic perfusion have been described extensively during
critical illness. Also, digestive secretory function (essential for
degradation of more complex nutrients) may be qualitatively
or quantitatively affected, as neurohumoral control is frequently
impaired. Furthermore, intestinal motility is possibly inappro-
priate for optimal digestion and absorption of nutrients due to
the persistence of migrating motor complexes during feeding
[2,8].
Conducting studies assessing intestinal absorption in ICU
patients is a difficult task. In particular, caution should be
taken when interpreting the kinetics of 3-O MG (to represent
glucose) absorption in the ICU setting. ICU patients do
indeed show pharmacokinetic differences compared with
normal individuals, including increased volume of distribution
and variable clearance of substances [9,10]. In septic
patients, the volume of distribution of hydrophilic substances
is often greater due to an increased capillary permeability
resulting in fluid shifts from the intravascular compartment to
the interstitial space. Distribution volume may also be
increased in ICU patients by the presence of mechanical
ventilation, hypoalbuminaemia (increased capillary leakage),
extracorporeal circuits, postsurgical drains, or burn injury
[10]. The resulting effect would be a decreased plasma
concentration of the molecule with a risk of misinterpretation
of some important kinetic parameters (area under concentration-
time curve, maximal concentration, time to peak concen-
tration). This may be of particular relevance if the sampling
period is relatively short. To circumvent this problem, quanti-
fication of urinary excretion of the test substance during
prolonged urinary collection may be preferable. Alternatively,
the so called ‘dual probe’ method has been proposed; in this
method, simultaneous administration of probe substances
that respond in a similar way to variables such as extra-
cellular fluid volume or renal clearance enables calculation of
urinary excretion ratios, thereby eliminating the effect of
these factors [4].
Another observation from Chapman and colleagues’ study is
the finding that gastric emptying was inversely related to
baseline blood glucose, such that elevated blood glucose
levels were associated with slower gastric emptying. This
confirms previous data from animal as well as human studies
demonstrating a deleterious effect of hyperglycaemia on
gastric emptying [11]. Also, previous studies have suggested
that small intestinal [12] and gallbladder motility [13] may be
inhibited by a hyperglycaemic state. Glucose control may
thus be important for optimal tolerance and absorption of
nutrients in ICU patients.
Future work should thus aim to confirm whether absorptive
capacity of the gut is indeed impaired during critical illness
and to determine the causes and mechanisms of this. With
this aim in view, further development and validation of tools
enabling reliable assessment of nutrient absorption in the ICU
setting would be eminently desirable.
Competing interests
The author declares that he has no competing interests.
References
1. Chapman M, Fraser R, Matthews G, Russo A, Bellon M, Besanko
LK, Jones K, Butler R, Chatterton B, Horowitz M: Glucose
absorption and gastric emptying in critical illness. Crit Care
2009, 13:R140.
2. Chapman MJ, Nguyen NQ, Fraser RJ: Gastrointestinal motility
and prokinetics in the critically ill. Curr Opin Crit Care 2007,
13:187-194.
3. Heyland DK, Tougas G, King D, Cook DJ: Impaired gastric emp-
tying in mechanically ventilated, critically ill patients. Intensive
Care Med 1996, 22:1339-1344.
4. Zuckerman MJ, Menzies IS, Ho H, Gregory GG, Casner NA,
Crane RS, Hernandez JA: Assessment of intestinal permeabil-
ity and absorption in cirrhotic patients with ascitis using com-
bined sugar probes. Dig Dis Sci 2004, 49:621-626.
5. Sharpstone D, Neild P, Crane R, Taylor C, Hodgson C, Sherwood
R, Gazzard B, Bjarnason I: Small intestinal transit, absorption,
and permeability in patients with AIDS with and without diar-
rhea. Gut 1999, 45:70-76.
6. Martin GR, Meddings JB, Sigalet DL: 3-O methylglucose
absorption in vivo correlates with nutrient absorption and
intestinal surface area in experimental short bowel syndrome.
JPEN 2003, 27:65-70.
7. Strack van Schijndel RJM, Wierdsma NJ, Van Heijningen EMB,
Weijs PJM, de Groot SDW, Girbes ARJ: Fecal energy losses in
enterally fed intensive care patients: an explorative study
using bomb calorimetry. Clin Nutr 2006, 25:758-764.
8. Dive A, Miesse C, Jamart J, Evrard P, Gonzalez M, Installe E: Duo-
denal motor response to continuous enteral feeding is
impaired in mechanically ventilated patients. Clin Nutr 1994,
13:302-306.
9. Boucher B, Wood C, Swanson J: Pharmacokinetic changes in
critical illness. Crit Care Clin 2006, 22:255-271.
10. Roberts J, Lipman J: Pharmacokinetic issues for antibiotics in
the critically ill patient. Crit Care Med 2009, 7:840-851.
11. Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne
C:  Physiological hyperglycemia slows gastric emptying in
normal subjects and patients with insulin-dependent diabetes
mellitus. Gastroenterology 1997, 113:60-66.
12. Björnsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U,
Abrahamsson H: Effects of hyperglycemia on interdigestive
gastrointestinal motility in humans. Scand J Gastroenterol
1994, 29:1096-1104.
13. Gielkens HA, Van Oostayen JA, Frölich M, Biemond I, Lamers CB,
Masclee AA: Dose-dependent inhibition of postprandial gall-
bladder motility and plasma hormone secretion during acute
hyperglycemia. Scand J Gastroenterol 1998, 33:1074-1079.